Saved in:
Bibliographic Details
Main Authors: C. Richard, M.A. Cuadrado, M. Prieto, J. Batlle, M.F. López Fernández, M.L. Rodríguez Salazar, C. Bello, M. Recio, T. Santoro, GOMEZ CASARES, MARIA TERESA, A. Zubizarreta
Format: Recurso digital
Language:
Published: Zenodo 1990
Online Access:https://doi.org/10.5281/zenodo.18337764
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866901891840999424
author C. Richard
M.A. Cuadrado
M. Prieto
J. Batlle
M.F. López Fernández
M.L. Rodríguez Salazar
C. Bello
M. Recio
T. Santoro
GOMEZ CASARES, MARIA TERESA
A. Zubizarreta
author_facet C. Richard
M.A. Cuadrado
M. Prieto
J. Batlle
M.F. López Fernández
M.L. Rodríguez Salazar
C. Bello
M. Recio
T. Santoro
GOMEZ CASARES, MARIA TERESA
A. Zubizarreta
contents <p>This article reports a case of acquired von Willebrand disease (AvWD) associated with IgA lambda multiple myeloma. No circulating inhibitor was detected. Multimeric analysis showed a decrease in all-sized von Willebrand factor (vWF) multimers with a type IA pattern. After DDAVP infusion, larger vWF multimers appeared transiently in plasma and were progressively cleared, suggesting increased removal from circulation. Indirect immunofluorescence using a monoclonal antibody demonstrated selective absorption of vWF into myelomatous plasma cells. The findings support a new pathophysiological mechanism of AvWD in multiple myeloma and potentially other lymphoproliferative disorders.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_18337764
institution Zenodo
language
publishDate 1990
publisher Zenodo
record_format zenodo
spellingShingle Acquired von Willebrand Disease in Multiple Myeloma Secondary to Absorption of von Willebrand Factor by Plasma Cells
C. Richard
M.A. Cuadrado
M. Prieto
J. Batlle
M.F. López Fernández
M.L. Rodríguez Salazar
C. Bello
M. Recio
T. Santoro
GOMEZ CASARES, MARIA TERESA
A. Zubizarreta
<p>This article reports a case of acquired von Willebrand disease (AvWD) associated with IgA lambda multiple myeloma. No circulating inhibitor was detected. Multimeric analysis showed a decrease in all-sized von Willebrand factor (vWF) multimers with a type IA pattern. After DDAVP infusion, larger vWF multimers appeared transiently in plasma and were progressively cleared, suggesting increased removal from circulation. Indirect immunofluorescence using a monoclonal antibody demonstrated selective absorption of vWF into myelomatous plasma cells. The findings support a new pathophysiological mechanism of AvWD in multiple myeloma and potentially other lymphoproliferative disorders.</p>
title Acquired von Willebrand Disease in Multiple Myeloma Secondary to Absorption of von Willebrand Factor by Plasma Cells
url https://doi.org/10.5281/zenodo.18337764